Picture of Cannabis Poland SA logo

CBD Cannabis Poland SA Share Price

0.000.00%
pl flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Momentum

Relative Strength (%)
1m-2.82%
3m+52.39%
6m+25.19%
1yr+45.21%
Volume Change (%)
10d/3m-79.89%
Price vs... (%)
52w High-45.96%
50d MA-1.99%
200d MA+39.3%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)n/a
PEG Ratio (f)n/a
EPS Growth (f)n/a
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value66.69
Price to Tang. Book66.97
Price to Free Cashflown/a
Price to Sales97.77
EV to EBITDAn/a

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-202.02%
Return on Equity-174.63%
Operating Margin-325.37%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202331st Dec 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of Cannabis Poland SA EPS forecast chart

Profile Summary

Cannabis Poland SA, formerly Telehorse SA, is a Poland-based company engaged in the Pharmaceutical and Medicine Manufacturing activity. The Company focuses on operating in the field of production and sale of pharmaceutical and medical products, with the main focus on vaporization products containing cannabinoids manufactured from cannabis. The Company also expands its activity to include other products than pharmaceuticals, such as cosmetics, oils containing cannabinoids for human and animals and photovoltaic cells. The Company is engaged in research and development of a Cannabidiol (CBD)/ Tetrahydrocannabinol-based (THC-based) pharmaceutical for use in the treatment of seizures associated with drug-resistant epilepsy.

Directors

Last Annual
December 31st, 2022
Last Interim
December 31st, 2022
Incorporated
February 7th, 2012
Public Since
April 9th, 2013
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
pl flag iconWarsaw Stock Exchange
Shares in Issue
34,782,600

CBD Share Price Performance

Upcoming Events for CBD

Similar to CBD

Picture of Bioceltix SA logo

Bioceltix SA

pl flag iconWarsaw Stock Exchange

Picture of Biogened SA logo

Biogened SA

pl flag iconWarsaw Stock Exchange

Picture of BioMaxima SA logo

BioMaxima SA

pl flag iconWarsaw Stock Exchange

Picture of Celon Pharma SA logo

Celon Pharma SA

pl flag iconWarsaw Stock Exchange

Picture of Cosma SA logo

Cosma SA

pl flag iconWarsaw Stock Exchange

FAQ